Search

Your search keyword '"Giorgino, Toni"' showing total 52 results

Search Constraints

Start Over You searched for: Author "Giorgino, Toni" Remove constraint Author: "Giorgino, Toni" Database MEDLINE Remove constraint Database: MEDLINE
52 results on '"Giorgino, Toni"'

Search Results

1. mdCATH: A Large-Scale MD Dataset for Data-Driven Computational Biophysics.

2. mdCATH: A Large-Scale MD Dataset for Data-Driven Computational Biophysics.

3. The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets.

4. Self-organizing maps of unbiased ligand-target binding pathways and kinetics.

5. AlloViz: A tool for the calculation and visualisation of protein allosteric communication networks.

6. Machine learning coarse-grained potentials of protein thermodynamics.

8. Maternal immune activation leads to defective brain-blood vessels and intracerebral hemorrhages in male offspring.

9. A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis.

10. Classification Model for the Second Extracellular Loop of Class A GPCRs.

11. SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions.

12. A novel hotspot of gelsolin instability triggers an alternative mechanism of amyloid aggregation.

13. TorchMD: A Deep Learning Framework for Molecular Simulations.

14. Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes.

15. Computational and Experimental Characterization of NF023, A Candidate Anticancer Compound Inhibiting cIAP2/TRAF2 Assembly.

16. GPCRmd uncovers the dynamics of the 3D-GPCRome.

17. Publisher Correction: GPCRmd uncovers the dynamics of the 3D-GPCRome.

18. The structure of N184K amyloidogenic variant of gelsolin highlights the role of the H-bond network for protein stability and aggregation properties.

19. Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients.

20. High-resolution crystal structure of gelsolin domain 2 in complex with the physiological calcium ion.

21. Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients.

22. Exploring the role of interdisciplinarity in physics: Success, talent and luck.

23. Nanobody interaction unveils structure, dynamics and proteotoxicity of the Finnish-type amyloidogenic gelsolin variant.

24. Analysis Libraries for Molecular Trajectories: A Cross-Language Synopsis.

25. Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project.

26. Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project.

27. Synthesis, molecular modelling studies and biological evaluation of new oxoeicosanoid receptor 1 agonists.

28. Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia.

29. Defective Amplifying Pathway of β-Cell Secretory Response to Glucose in Type 2 Diabetes: Integrated Modeling of In Vitro and In Vivo Evidence.

30. High-Throughput Automated Preparation and Simulation of Membrane Proteins with HTMD.

31. PlayMolecule ProteinPrepare: A Web Application for Protein Preparation for Molecular Dynamics Simulations.

32. Drug Discovery and Molecular Dynamics: Methods, Applications and Perspective Beyond the Second Timescale.

33. Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain.

34. Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis.

35. MEMBPLUGIN: studying membrane complexity in VMD.

36. Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH.

37. Identification of slow molecular order parameters for Markov model construction.

38. Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations.

39. A High-Throughput Steered Molecular Dynamics Study on the Free Energy Profile of Ion Permeation through Gramicidin A.

40. The Virtual Physiological Human ToolKit.

41. Wireless support to poststroke rehabilitation: MyHeart's neurological rehabilitation concept.

42. Sensor evaluation for wearable strain gauges in neurological rehabilitation.

43. An automated voice response system for anticoagulant therapy management.

44. Matching incomplete time series with dynamic time warping: an algorithm and an application to post-stroke rehabilitation.

45. Remote support for stroke rehabilitation: MyHeart's "neurological rehabilitation" concept.

46. A multivariate time-warping based classifier for gesture recognition with wearable strain sensors.

47. Health dialog systems for patients and consumers.

49. Posture classification via wearable strain sensors for neurological rehabilitation.

50. Automated spoken dialogue system for hypertensive patient home management.

Catalog

Books, media, physical & digital resources